Refine by
Human Diagnostic Articles & Analysis
11 news found
Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced release of its new line of Human Hybrid IgM Control Monoclonal Antibodies for research applications, covering a range of diseases such as CMV, HSV, MeV, MuV, RuV, and VZV.Characteristic disease state sera are serum samples derived from individuals with ...
Lifespin will now be able to scan and create the corresponding digitized, quantitative metabolic profiles involving as many as 300,000 human samples per year. “These additional resources will support our recently launched commercial services which, for the first time, will provide the pharmaceutical and biobanking industries with access to our proprietary metabolic ...
This antibody is used for research only, not for human, therapeutic or diagnostic applications. The high specificity and sensitivity of antibodies are unique advantages in biomedical research applications. ...
The OPTI Rapid Lysis Buffer has shown a diagnostic sensitivity and specificity of 100 % when compared to magnetic bead extraction. The PCR testing workflow for SARS-CoV-2 from OPTI Medical comes with the following benefits: High sensitivity and specificity as proven by internal and external validations Extraction-free sample handling with savings in instruments, reagents, ...
These features make the test more accessible than other diagnostic methods that physicians use to evaluate issues with memory and thinking. ...
C2N Diagnostics, which offers the PrecivityAD™ blood test that can help detect if certain markers for Alzheimer’s disease are in the brain, now has its analytical validation results available for review. ...
The U.S. Department of Health and Human Services’ Centers for Medicare & Medicaid Services manages CLIA certification. ...
These features make the test more accessible than other diagnostic methods that physicians use to evaluate issues with memory and thinking. ...
(NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of Sample to Insight molecular diagnostics and sample preparation technologies, today announced that they have entered into an amendment to their acquisition agreement under which Thermo Fisher has commenced a tender offer to acquire all of the ordinary shares of QIAGEN. ...
The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the U.S. ...
The OPTI SARS-CoV-2 RT-PCR test kit detects human RNase P as an internal sample control and endogenous nucleic acid to control for sample addition, extraction and amplification. ...